Inhibrx Biosciences (INBX) Depreciation & Amortization (CF) (2023 - 2026)
Inhibrx Biosciences (INBX) reported Depreciation & Amortization (CF) of $523,000 for Q2 2026, down 21.0% from $662,000 a year earlier.
Powered by 
Analysis
Inhibrx Biosciences (INBX) Depreciation & Amortization (CF) (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Inhibrx Biosciences' Depreciation & Amortization (CF) came in at $2.33 million, down 16.3% year-over-year; for FY2025, it was $2.48 million, up 8.7% from FY2024.
- By year, Depreciation & Amortization (CF) came in at $2.29 million in FY2024 (+91.9%) and $1.19 million in FY2023.
- The Q2 2026 figure ranks as the lowest quarterly Depreciation & Amortization (CF) since Q2 2024.
- Year over year, Depreciation & Amortization (CF) gained in four of the last seven quarters, with growth averaging 49.4%.
- The high point for year-over-year Depreciation & Amortization (CF) in five years was Q3 2024 (growth of 150.0%); the low point was Q3 2025 (a decline of 23.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 545.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.12 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 192.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 726.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.61 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.12 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 132.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.58 Bn |
| 10 | Inhibrx Biosciences | 1.33 Bn | 760.41 Mn | - | 523,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 523,000.00 |
| Mar 31, 2026 | 537,000.00 |
| Dec 31, 2025 | 564,000.00 |
| Sep 30, 2025 | 582,000.00 |
| Jun 30, 2025 | 662,000.00 |
| Mar 31, 2025 | 675,000.00 |
| Dec 31, 2024 | 689,000.00 |
| Sep 30, 2024 | 760,000.00 |
| Jun 30, 2024 | 475,000.00 |
| Mar 31, 2024 | 360,000.00 |
| Dec 31, 2023 | 298,000.00 |
| Sep 30, 2023 | 304,000.00 |
| Jun 30, 2023 | 295,000.00 |
API Access
Inhibrx Biosciences Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=INBX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "INBX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=INBX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();